(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are ChinaNet Online Holdings, China Automotive Systems, and CymaBay Therapeutics.

Rank Financial Asset Price Change Updated (EST)
1 ChinaNet Online Holdings (CNET) 1.01 10.99% 2022-09-16 16:17:06
2 China Automotive Systems (CAAS) 4.53 7.09% 2022-09-16 05:11:06
3 CymaBay Therapeutics (CBAY) 4.09 6.23% 2022-09-16 07:42:15
4 Axogen (AXGN) 11.74 5.58% 2022-09-15 21:11:07
5 Atlanticus Holdings Corporation (ATLC) 29.69 3.59% 2022-09-15 19:14:08
6 BioLineRx Ltd. (BLRX) 1.59 3.25% 2022-09-16 01:43:14
7 SK Telecom (SKM) 20.39 3.24% 2022-09-16 14:56:48
8 Astrotech Corporation (ASTC) 0.46 3.22% 2022-09-15 19:06:06
9 Bridgeline Digital (BLIN) 1.64 3.14% 2022-09-16 01:41:14
10 Newmont Mining (NEM) 43.73 3.14% 2022-09-16 14:46:09

The three biggest losers today are ClearSign Technologies Corporation, Accelerate Diagnostics, and FuboTV.

Rank Financial Asset Price Change Updated (EST)
1 ClearSign Technologies Corporation (CLIR) 0.95 -24% 2022-09-16 15:06:09
2 Accelerate Diagnostics (AXDX) 1.64 -11.35% 2022-09-15 21:10:07
3 FuboTV (FUBO) 4.45 -11.28% 2022-09-16 14:51:55
4 International Paper Company (IP) 35.23 -11.21% 2022-09-16 14:56:48
5 Momo (MOMO) 4.57 -10.14% 2022-09-16 14:58:25
6 Riot Blockchain (RIOT) 6.66 -9.73% 2022-09-16 14:50:47
7 Marathon (MARA) 10.94 -9.39% 2022-09-16 14:58:13
8 Chembio Diagnostics (CEMI) 0.44 -9.28% 2022-09-16 10:42:15
9 Pacific Biosciences of California (PACB) 6.05 -8.47% 2022-09-16 14:59:10
10 Xenetic Biosciences (XBIO) 0.66 -8.47% 2022-09-16 14:51:45

Winners today

1. ChinaNet Online Holdings (CNET) – 10.99%

ZW Data Action Technologies Inc. provides precision marketing and omnichannel advertising services in China through its subsidiaries. Through its Internet portals 28.com, liansuo.com, it offers precision marketing and Internet advertising. These provide tools for advertisers to create sales channels through franchisees and sales agents as well as distributors and/or resellers. It also offers services and products based on blockchain technology. It also offers digital marketing, e-commerce, online and offline advertising, marketing, research, development and technical support for block chain businesses. The previous name of the company was ChinaNet Online Holdings, Inc., but it changed its name in October 2020 to ZW Data Action Technologies Inc. ZW Data Action Technologies Inc. is located in Beijing, People’s Republic of China.

NASDAQ ended the session with ChinaNet Online Holdings jumping 10.99% to $1.01 on Friday, following the last session’s upward trend. NASDAQ slid 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for ChinaNet Online Holdings is 1734270 which is 146.76% above its average volume of 702803.

ChinaNet Online Holdings’s last close was $0.91, 44.17% below its 52-week high of $1.63.

ChinaNet Online Holdings’s Revenue

Year-on-year quarterly revenue growth declined by 52.3%, now sitting on 38.98M for the twelve trailing months.

ChinaNet Online Holdings’s Stock Yearly Top and Bottom Value

ChinaNet Online Holdings’s stock is valued at $1.01 at 17:32 EST, way under its 52-week high of $1.63 and way above its 52-week low of $0.28.

ChinaNet Online Holdings’s Moving Average

ChinaNet Online Holdings’s value is way above its 50-day moving average of $0.73 and way above its 200-day moving average of $0.69.

More news about ChinaNet Online Holdings.

2. China Automotive Systems (CAAS) – 7.09%

China Automotive Systems, Inc., via its subsidiaries, produces and sells components and systems for automobiles in China. It manufactures rack-and-pinion power steering wheels for cars and light duty trucks; integral power steering tools for heavy duty vehicles; power steering parts and components for light duty automobiles; sensor modules; automotive steering systems, columns and auto electronic and hydraulic power steering system and parts. China Automotive Systems, Inc. markets parts for automobiles in North America, Brazil, as well providing after-sales services and support services. It sells its products primarily to original equipment manufacturers. China Automotive Systems, Inc., was established in 1999. It is located in Jingzhou City, People’s Republic of China.

NASDAQ ended the session with China Automotive Systems jumping 7.09% to $4.53 on Friday, following the last session’s upward trend. NASDAQ slid 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for China Automotive Systems is 200115 which is 79.49% above its average volume of 111488.

China Automotive Systems’s last close was $4.53, 11.52% under its 52-week high of $5.12.

China Automotive Systems’s Sales

China Automotive Systems’s sales growth is 11.4% for the present quarter and a decline by 5.3% for the next. The company’s growth estimates for the present quarter is 500% and a drop 62.5% for the next.

China Automotive Systems’s Revenue

Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 510.6M for the twelve trailing months.

China Automotive Systems’s Stock Yearly Top and Bottom Value

China Automotive Systems’s stock is valued at $4.53 at 17:32 EST, way under its 52-week high of $5.12 and way higher than its 52-week low of $2.20.

China Automotive Systems’s Moving Average

China Automotive Systems’s worth is way higher than its 50-day moving average of $3.39 and way higher than its 200-day moving average of $2.94.

More news about China Automotive Systems.

3. CymaBay Therapeutics (CBAY) – 6.23%

CymaBay Therapeutics, Inc., is a biopharmaceutical company in clinical stage. It focuses on the development and delivery of therapies for liver disease and other chronic conditions. Seladelpar, a selective agonist for peroxisome proliferator activated receiver delta (MBX-8025), is the company’s leading product candidate. It has successfully completed Phase II clinical trials in patients with primary biliary cholangitis and nonalcoholic steatohepatitis. The company is also developing MBX-2982, which is currently in Phase 2a clinical trial to treat hypoglycemia and other conditions in diabetics. CB-0406 is in Phase 1 clinical trials for inflammation diseases. CB-001 is a preclinical stage candidate for a product. It’s a G-protein-coupled receptor to omega-3 fatty acid, such as docosahexaenoic, for treatment of liver/gut disease. DiaTex, Inc. has granted it a license to commercialize therapeutic products containing halofenate, its derivatives, enantiomers, and analogs. Janssen Pharmaceuticals, Inc. holds the worldwide license to Janssen Pharmaceuticals, Inc. for research, development, and marketing of compounds that have activity against an unidentified metabolic disease target. The company used to be known as Metabolex, Inc. CymaBay Therapeutics, Inc. is located in Newark, California.

NASDAQ ended the session with CymaBay Therapeutics rising 6.23% to $4.09 on Friday while NASDAQ dropped 0.9% to $11,448.40.

Volume

Today’s last reported volume for CymaBay Therapeutics is 307949 which is 56.43% below its average volume of 706800.

CymaBay Therapeutics’s last close was $4.09, 13.71% under its 52-week high of $4.74.

The company’s growth estimates for the ongoing quarter and the next is 11.8% and 6.1%, respectively.

CymaBay Therapeutics’s Stock Yearly Top and Bottom Value

CymaBay Therapeutics’s stock is valued at $4.09 at 17:32 EST, way below its 52-week high of $4.74 and way above its 52-week low of $1.67.

CymaBay Therapeutics’s Moving Average

CymaBay Therapeutics’s worth is way higher than its 50-day moving average of $3.62 and way higher than its 200-day moving average of $3.06.

More news about CymaBay Therapeutics.

4. Axogen (AXGN) – 5.58%

AxoGen, Inc., along with its subsidiaries, creates and markets surgical options for peripheral nerve damage. Avance Nerve Graft is a bioactive, off-the shelf, human nerve allograft that can be used to bridge severed nerves. AxoGuard Nerve Connector (a porcine Submucosa ECM product) allows for the tensionless repair and coaptation of damaged peripheral nerves. AxoGuard Nerve Protection, which is a porcine ECM product, protects and wraps nerves and prevents soft tissue attachments. Axoguard Nerve Cap is a porcine submucosa ECM that protects a peripheral nerve’s end and separates it from its surrounding environment. It can also be used to cover the surgical beds with Avive Soft Tissue Membrane. AxoTouch Two Point Discriminator is also offered by the company. This tool measures the innervation density and surface area of skin. The company supplies its products to various hospitals and surgery centers in the United States and abroad. AxoGen, Inc. has its headquarters in Alachua, Florida.

NASDAQ ended the session with Axogen jumping 5.58% to $11.74 on Friday, after two successive sessions in a row of gains. NASDAQ slid 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Axogen is 364881 which is 77.84% above its average volume of 205170.

Axogen’s last close was $11.74, 29.99% under its 52-week high of $16.77.

Axogen’s Sales

Axogen’s sales growth is 5.8% for the current quarter and 19.2% for the next.

Axogen’s Revenue

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 128.2M for the twelve trailing months.

Axogen’s Stock Yearly Top and Bottom Value

Axogen’s stock is valued at $11.74 at 17:32 EST, way below its 52-week high of $16.77 and way higher than its 52-week low of $6.87.

Axogen’s Moving Average

Axogen’s worth is way above its 50-day moving average of $9.77 and way above its 200-day moving average of $9.00.

More news about Axogen.

5. Atlanticus Holdings Corporation (ATLC) – 3.59%

Atlanticus Holdings Corporation offers credit, and other financial products and services to American customers. The company operates two sections, Credit and Other Investments and Auto Finance. Credit and Other Investments is a segment that originates consumer loans. These include private label and general-purpose credit cards. Lenders can source these products through many channels including direct mail solicitation and retail point-of sale. Credit and Other Investments also offers credit to customers who are looking for credit to purchase various items and services. This includes furniture, medical services and healthcare. The segment invests in credit card receivables and provides services to them. It also offers service such as loan servicing and risk management for customers. Auto Finance purchases or services automobile loans that are secured by vehicles from pre-qualified networks of automotive dealers and finance companies. This includes used cars, buy-here pay-here and new car businesses. The segment offers installment loans and floor plan financing. Formerly known as CompuCredit Holdings Corporation, the company changed its name in November 2012 to Atlanticus Holdings Corporation. Atlanticus Holdings Corporation is located in Atlanta, Georgia. It was established in 1996.

NASDAQ ended the session with Atlanticus Holdings Corporation jumping 3.59% to $29.69 on Friday while NASDAQ fell 0.9% to $11,448.40.

Volume

Today’s last reported volume for Atlanticus Holdings Corporation is 32500 which is 10.72% below its average volume of 36403.

Atlanticus Holdings Corporation’s last close was $29.69, 67.72% under its 52-week high of $91.98.

The company’s growth estimates for the ongoing quarter and the next is a negative 52.1% and a negative 44.1%, respectively.

Atlanticus Holdings Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 450.36M for the twelve trailing months.

Atlanticus Holdings Corporation’s Stock Yearly Top and Bottom Value

Atlanticus Holdings Corporation’s stock is valued at $29.69 at 17:32 EST, way under its 52-week high of $91.98 and way higher than its 52-week low of $25.65.

Atlanticus Holdings Corporation’s Moving Average

Atlanticus Holdings Corporation’s worth is way under its 50-day moving average of $35.93 and way under its 200-day moving average of $47.96.

More news about Atlanticus Holdings Corporation.

6. BioLineRx Ltd. (BLRX) – 3.25%

BioLineRx Limited. is a biopharmaceutical company that is in the clinical stage. It focuses its efforts on oncology. The company’s pipeline includes clinical-stage therapeutic candidates. These include BL-8044, a peptide that can be used to treat solid tumors and hematological malignancies. AGI-134 is an immuno-oncology agent for developing solid tumors. BL-5010 is a pen-like, customized applicator designed for non-surgical skin lesion removal. MSD has a collaboration agreement with the company in the field of cancer immunotherapy. The MD Anderson Cancer Center will investigate the combination BL-80440 and KEYTRUDA, a drug that treats pancreatic cancer. Genentech Inc. will investigate the use of BL-8040 to treat solid tumors. BioLineRx Ltd. is an Israeli company that was established in 2003. Its headquarters are in Hevel Modi’in.

NASDAQ ended the session with BioLineRx Ltd. rising 3.25% to $1.59 on Friday, following the last session’s upward trend. NASDAQ slid 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for BioLineRx Ltd. is 323130 which is 128.83% above its average volume of 141208.

BioLineRx Ltd.’s last close was $1.59, 49.52% under its 52-week high of $3.15.

The company’s growth estimates for the present quarter and the next is 53.3% and 53.3%, respectively.

BioLineRx Ltd.’s Stock Yearly Top and Bottom Value

BioLineRx Ltd.’s stock is valued at $1.59 at 17:32 EST, way under its 52-week high of $3.15 and way above its 52-week low of $1.01.

BioLineRx Ltd.’s Moving Average

BioLineRx Ltd.’s value is above its 50-day moving average of $1.53 and under its 200-day moving average of $1.63.

More news about BioLineRx Ltd..

7. SK Telecom (SKM) – 3.24%

SK Telecom Co., Ltd. offers wireless telecommunications services in South Korea. Cellular Services, Fixed-Line Telecommunications Services and Other Businesses are the three main segments of the company. Cellular Services offers voice and data wireless transmissions, Internet of Things solutions platform cloud smart factory solutions subscription, metaverse platform-based service and also sells wireless devices. Fixed-Line Telecommunications Services provides fixed-line phone services and broadband Internet services. It also offers media platform services such as cable TV, Internet protocol TV, and business communication services. In addition to portal and television shopping, the Other Businesses segment provides services for other businesses under T-commerce. It also provides services such as call center management and base station maintenance, information gathering, consulting, software supply and development, digital contents sourcing, quant information and communications, content and mastering sound albums sales, product manufacturing and sale, and trading in anti-theft devices and surveillance equipment. The company has a total of 3.6 million subscribers to fixed lines and 31.9million wireless subscribers as of December 31, 2021. SK Telecom Company Limited, based in Seoul in South Korea was founded in 1984.

NYSE ended the session with SK Telecom jumping 3.24% to $20.39 on Friday while NYSE fell 1.01% to $14,573.91.

Volume

Today’s last reported volume for SK Telecom is 825535 which is 95.02% above its average volume of 423287.

SK Telecom’s last close was $19.75, 61.82% under its 52-week high of $51.73.

SK Telecom’s Revenue

Year-on-year quarterly revenue growth grew by 4%, now sitting on 16.91T for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SK Telecom’s stock is considered to be overbought (>=80).

SK Telecom’s Stock Yearly Top and Bottom Value

SK Telecom’s stock is valued at $20.39 at 17:32 EST, way below its 52-week high of $51.73 and higher than its 52-week low of $20.35.

SK Telecom’s Moving Average

SK Telecom’s worth is below its 50-day moving average of $22.12 and way below its 200-day moving average of $27.08.

More news about SK Telecom.

8. Astrotech Corporation (ASTC) – 3.22%

Astrotech Corporation is a global science and technology commercialization and development company. The company operates in three segments: Astrotech Technologies, Inc. (1st Detect Corporation 1st Detect) and AgLAB Inc. (AgLAB). The ATI segment licenses and owns the AMS Technology platform mass spectrometry technique. 1. Detect manufactures explosives as well as narcotics trace detections that can be used at borders, secure facilities and airports. The segment produces TRACER 1000 which is a mass-spectrometer-based explosives trace detection to replace explosives detectors at borders, airports and cargo facilities. AgLAB is a segment of AgLAB that develops AgLAB 1000, which is a mass-spectrometer designed for the cannabis and hemp markets. BreathTest 1000, which is a tool that analyzes the breath for volatile organic compound and metabolites in breaths of people, was also developed by AgLAB. In 2009, the company, formerly called SPACEHAB, Inc., changed its name and became Astrotech Corporation. Astrotech Corporation was founded in 1984 and is located in Austin, Texas.

NASDAQ ended the session with Astrotech Corporation jumping 3.22% to $0.46 on Friday while NASDAQ fell 0.9% to $11,448.40.

Volume

Today’s last reported volume for Astrotech Corporation is 89456 which is 56.24% below its average volume of 204440.

Astrotech Corporation’s last close was $0.46, 59.57% below its 52-week high of $1.15.

Astrotech Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 140%, now sitting on 869k for the twelve trailing months.

Astrotech Corporation’s Stock Yearly Top and Bottom Value

Astrotech Corporation’s stock is valued at $0.46 at 17:32 EST, way below its 52-week high of $1.15 and way above its 52-week low of $0.41.

Astrotech Corporation’s Moving Average

Astrotech Corporation’s worth is under its 50-day moving average of $0.46 and way below its 200-day moving average of $0.59.

More news about Astrotech Corporation.

9. Bridgeline Digital (BLIN) – 3.14%

Bridgeline Digital, Inc. is a US-based digital engagement firm. Bridgeline Digital’s Unbound platform allows developers and companies to build websites, online applications and stores using the company. Bridgeline Unbound Experience Manager is a content and marketing management engine; Bridgeline Unbound Content Manager allows non-technical users create, edit and publish content using a browser-based interface. Bridgeline Unbound Commerce is an online B2B/B2C commerce solution that allows users manage international and domestic commerce projects. Bridgeline Unbound Marketing is an online marketing solution designed to drive traffic to websites through targeted and personalized marketing automation flows. Bridgeline Unbound Insights allows users to monitor, optimize, and measure web properties, as well as record detailed events, extract data, and analyze statistically. Bridgeline Unbound Social is a social media management tool that allows customers to create customized watch lists. Bridgeline Unbound Franchises provides a web content management platform and an e-commerce platform for multi-unit franchises. The company also offers digital strategy, web development, usability engineering and information architecture services. It also provides application monitoring, emergency responses, version control and load balancing services. They can provide virus protection and managed firewall security services. It also offers OrchestraCMS and Celebros Search digital solutions by Bridgeline. Through its direct sales force, it serves vertical markets such as banking, financial services, life sciences and retail brands, tech, regional banks and credit unions, associations, foundations, and technology. Bridgeline Software, Inc. used to be the company’s name. Bridgeline Digital, Inc. is located in Burlington, Massachusetts.

NASDAQ ended the session with Bridgeline Digital jumping 3.14% to $1.64 on Friday while NASDAQ slid 0.9% to $11,448.40.

Volume

Today’s last reported volume for Bridgeline Digital is 433689 which is 280.93% above its average volume of 113848.

Bridgeline Digital’s last close was $1.64, 64.11% below its 52-week high of $4.57.

The company’s growth estimates for the present quarter and the next is 90.2% and 85%, respectively.

Bridgeline Digital’s Revenue

Year-on-year quarterly revenue growth grew by 43.2%, now sitting on 15.95M for the twelve trailing months.

Bridgeline Digital’s Stock Yearly Top and Bottom Value

Bridgeline Digital’s stock is valued at $1.64 at 17:32 EST, way under its 52-week high of $4.57 and way above its 52-week low of $1.06.

Bridgeline Digital’s Moving Average

Bridgeline Digital’s value is way above its 50-day moving average of $1.38 and below its 200-day moving average of $1.69.

More news about Bridgeline Digital.

10. Newmont Mining (NEM) – 3.14%

Newmont Corporation is involved in exploration and production of gold. The company also searches for lead, copper, silver and zinc. It has assets and operations in Canada, Mexico and the Dominican Republic. It had 92.8 million ounces of proven and probable gold and a land area of 62.800 km as of December 31, 2021. Denver is the headquarters of this company, which was established in 1916.

NYSE ended the session with Newmont Mining rising 3.14% to $43.73 on Friday, after three sequential sessions in a row of losses. NYSE slid 1.01% to $14,573.91, following the last session’s downward trend on what was an all-around down trend exchanging session today.

Volume

Today’s last reported volume for Newmont Mining is 8908170 which is 5.41% below its average volume of 9418040.

Newmont Mining’s last close was $42.40, 50.91% below its 52-week high of $86.37.

The company’s growth estimates for the current quarter is 20.8% and a drop 1% for the next.

Newmont Mining’s Revenue

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 12.37B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Newmont Mining’s stock is considered to be overbought (>=80).

Newmont Mining’s Stock Yearly Top and Bottom Value

Newmont Mining’s stock is valued at $43.73 at 17:32 EST, under its 52-week low of $43.90.

Newmont Mining’s Moving Average

Newmont Mining’s value is way below its 50-day moving average of $56.49 and way below its 200-day moving average of $63.64.

More news about Newmont Mining.

Losers Today

1. ClearSign Technologies Corporation (CLIR) – -24%

ClearSign Technologies Corporation develops and designs products and technologies that improve operational performance, efficiency, safety and overall cost effectiveness of commercial and industrial systems in the United States. ClearSign Core Burner Technology consists a industrial burner body with a porous ceramic structure downstream or metal flame stabilizing devices; ClearSign Core Plug & Play technology allows for direct replacement of traditional refinery heaters; ClearSign Clear Flame Sensor is an electric flame sensor that can be used in industrial applications; ClearSign also offers ClearSign core boiler burner and ClearSign core flaring burners technologies. The company serves the chemical, petrochemical, energy and commercial boiler industries. ClearSign Combustion Corporation was the company’s former name. In November 2019, ClearSign Technologies Corporation took over. ClearSign Technologies Corporation was established in 2008. It is located in Seattle, Washington.

NASDAQ ended the session with ClearSign Technologies Corporation sliding 24% to $0.95 on Friday, after three successive sessions in a row of gains. NASDAQ fell 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for ClearSign Technologies Corporation is 118555 which is 145.91% above its average volume of 48209.

ClearSign Technologies Corporation’s last close was $1.25, 53.36% below its 52-week high of $2.68.

ClearSign Technologies Corporation’s Sales

ClearSign Technologies Corporation’s sales growth is 110.5% for the present quarter and 1474.1% for the next.

ClearSign Technologies Corporation’s Stock Yearly Top and Bottom Value

ClearSign Technologies Corporation’s stock is valued at $0.95 at 17:32 EST, way below its 52-week high of $2.68 and way higher than its 52-week low of $0.82.

ClearSign Technologies Corporation’s Moving Average

ClearSign Technologies Corporation’s worth is way below its 50-day moving average of $1.09 and way below its 200-day moving average of $1.26.

More news about ClearSign Technologies Corporation.

2. Accelerate Diagnostics (AXDX) – -11.35%

Accelerate Diagnostics, Inc., a company that specializes in in vitro diagnosis, offers solutions to diagnose serious infections across the United States, Europe, Middle East, and Asia. Accelerate Pheno, an in vitro diagnostic system that can identify and test for antibiotic susceptibility of pathogens linked to serious and health-related infections (gram-positive or gram-negative), is offered by the company. The company also offers the Accelerate PhenoTest test kit, which analyzes the results of the system and provides identification and susceptibility testing results to patients with suspected bacteremia and fungemia. These are life-threatening conditions that pose a high risk for death and morbidity. In December 2012, Accelerate Diagnostics, Inc. was established. The previous name of the company was Accelr8 Technology Corporation. Accelerate Diagnostics, Inc. is located in Tucson, Arizona.

NASDAQ ended the session with Accelerate Diagnostics dropping 11.35% to $1.64 on Friday while NASDAQ slid 0.9% to $11,448.40.

Volume

Today’s last reported volume for Accelerate Diagnostics is 751929 which is 36.77% below its average volume of 1189220.

Accelerate Diagnostics’s last close was $1.64, 77.19% below its 52-week high of $7.19.

The company’s growth estimates for the ongoing quarter is a negative 26.7% and positive 51.4% for the next.

Accelerate Diagnostics’s Revenue

Year-on-year quarterly revenue growth grew by 38%, now sitting on 13.29M for the twelve trailing months.

Accelerate Diagnostics’s Stock Yearly Top and Bottom Value

Accelerate Diagnostics’s stock is valued at $1.64 at 17:32 EST, way under its 52-week high of $7.19 and way above its 52-week low of $0.50.

Accelerate Diagnostics’s Moving Average

Accelerate Diagnostics’s worth is under its 50-day moving average of $1.69 and way under its 200-day moving average of $2.16.

More news about Accelerate Diagnostics.

3. FuboTV (FUBO) – -11.28%

FuboTV Inc. provides live streaming for entertainment, sports and news content throughout the United States. Customers can access the fuboTV platform via streaming devices as well as SmartTVs and computers. New York is the headquarters of this company.

NYSE ended the session with FuboTV dropping 11.28% to $4.45 on Friday while NYSE dropped 1.01% to $14,573.91.

Volume

Today’s last reported volume for FuboTV is 10464000 which is 36.6% below its average volume of 16507200.

FuboTV’s last close was $5.01, 85.73% under its 52-week high of $35.10.

FuboTV’s Sales

FuboTV’s sales growth is 102.2% for the current quarter and 99.7% for the next. The company’s growth estimates for the current quarter is a negative 18.6% and positive 5.9% for the next.

FuboTV’s Revenue

Year-on-year quarterly revenue growth grew by 119.9%, now sitting on 638.35M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FuboTV’s stock is considered to be oversold (<=20).

FuboTV’s Stock Yearly Top and Bottom Value

FuboTV’s stock is valued at $4.45 at 17:32 EST, way under its 52-week high of $35.10 and way higher than its 52-week low of $2.49.

FuboTV’s Moving Average

FuboTV’s value is way above its 50-day moving average of $3.60 and way under its 200-day moving average of $13.77.

More news about FuboTV.

4. International Paper Company (IP) – -11.21%

International Paper Company is a leading packaging company in the Americas, including the United States, Middle East, Europe and Africa. The company operates in two main segments, Industrial Packaging and Global Cellulose Fibers. Industrial Packaging produces containerboards. This includes linerboards in linerboard and medium. Global Cellulose Fibers provides fluff and market pulps for absorbent products such as diapers, feminine care and adult incontinence products. The company sells directly to converters and end users, but also through paper distributors, agents, resellers and representatives. It was established in Memphis, Tennessee in 1898.

NYSE ended the session with International Paper Company falling 11.21% to $35.23 on Friday while NYSE dropped 1.01% to $14,573.91.

Volume

Today’s last reported volume for International Paper Company is 9115680 which is 239.58% above its average volume of 2684390.

International Paper Company’s last close was $39.68, 29.86% below its 52-week high of $56.57.

International Paper Company’s Sales

International Paper Company’s sales growth is a negative 5.3% for the ongoing quarter and 9.4% for the next. The company’s growth estimates for the present quarter and the next is 5.9% and 82.1%, respectively.

International Paper Company’s Revenue

Year-on-year quarterly revenue growth grew by 13%, now sitting on 20.63B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

International Paper Company’s stock is considered to be overbought (>=80).

International Paper Company’s Stock Yearly Top and Bottom Value

International Paper Company’s stock is valued at $35.23 at 17:33 EST, way below its 52-week low of $40.13.

International Paper Company’s Moving Average

International Paper Company’s worth is way below its 50-day moving average of $42.56 and way under its 200-day moving average of $45.34.

More news about International Paper Company.

5. Momo (MOMO) – -10.14%

Hello Group Inc. offers mobile-based entertainment and social services in China. The company operates the Momo platform, which includes its Momo mobile app, along with various properties, features and functionalities. Momo’s mobile app connects people, facilitates interaction based on their location and interests, and various recreational activities including short videos and live talent shows. Tantan is a social dating and social networking app that allows users to make romantic connections and find interesting people. It offers live video chats, instant chats, value-added mobile marketing and many other services. It also allows users of its platform to stream a wide range of content and activities, including talk and talent shows as well casual chats and other interactions between viewers and broadcasters. In August 2021, the company changed its name from Momo Inc. to Hello Group Inc. Hello Group Inc. was founded in 2011. It is located in Beijing, People’s Republic of China.

NASDAQ ended the session with Momo sliding 10.14% to $4.57 on Friday, following the last session’s upward trend. NASDAQ slid 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Momo is 2792820 which is 62.4% above its average volume of 1719700.

Momo’s last close was $5.08, 63.69% under its 52-week high of $13.99.

Momo’s Sales

Momo’s sales growth is a negative 20.9% for the current quarter and a decline by 22.4% for the next. The company’s growth estimates for the present quarter and the next is a negative 37.5% and a negative 41.5%, respectively.

Momo’s Revenue

Year-on-year quarterly revenue growth declined by 9.3%, now sitting on 14.25B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Momo’s stock is considered to be overbought (>=80).

Momo’s Stock Yearly Top and Bottom Value

Momo’s stock is valued at $4.57 at 17:33 EST, way below its 52-week high of $13.99 and way higher than its 52-week low of $4.14.

Momo’s Moving Average

Momo’s worth is under its 50-day moving average of $4.78 and way under its 200-day moving average of $6.81.

More news about Momo.

6. Riot Blockchain (RIOT) – -9.73%

Riot Blockchain, Inc. and its affiliates focuses exclusively on Bitcoin mining in North America. It is present in three segments: Bitcoin Mining, Data Center Hosting and Electrical Products and Engineering. It had approximately 30907 active miners as of December 31, 2021. Riot Blockchain, Inc., was founded in 2000. It is located in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain falling 9.73% to $6.66 on Friday while NASDAQ fell 0.9% to $11,448.40.

Volume

Today’s last reported volume for Riot Blockchain is 10680800 which is 32.25% below its average volume of 15767200.

Riot Blockchain’s last close was $7.38, 84.05% under its 52-week high of $46.28.

The company’s growth estimates for the current quarter is a negative 81.8% and positive 106.2% for the next.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 244%, now sitting on 269.83M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Riot Blockchain’s stock is considered to be overbought (>=80).

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $6.66 at 17:33 EST, way below its 52-week high of $46.28 and way above its 52-week low of $4.02.

Riot Blockchain’s Moving Average

Riot Blockchain’s value is under its 50-day moving average of $7.01 and way under its 200-day moving average of $13.99.

More news about Riot Blockchain.

7. Marathon (MARA) – -9.39%

Marathon Digital Holdings, Inc. is a company that produces digital asset technology. It mines cryptocurrency with a particular focus on the Blockchain ecosystem and the creation of digital assets in the United States. It had 8,115 bitcoins as of December 31, 2021. This includes the 4,794 bitcoins in its investment fund. Marathon Patent Group, Inc. was the company’s former name. In February 2021, Marathon Digital Holdings, Inc. took over its business. Marathon Digital Holdings, Inc. is an American company that was founded in 2010. Its headquarters are located in Las Vegas, Nevada.

NASDAQ ended the session with Marathon falling 9.39% to $10.94 on Friday, after three sequential sessions in a row of losses. NASDAQ dropped 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Marathon is 11941400 which is 39.16% below its average volume of 19627900.

Marathon’s last close was $12.07, 85.54% below its 52-week high of $83.45.

Marathon’s Sales

Marathon’s sales growth is 42% for the ongoing quarter and 39.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 79.8% and 104.5%, respectively.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 465%, now sitting on 193.03M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon’s stock is considered to be overbought (>=80).

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $10.94 at 17:33 EST, way under its 52-week high of $83.45 and way higher than its 52-week low of $5.20.

Marathon’s Moving Average

Marathon’s worth is below its 50-day moving average of $11.94 and way under its 200-day moving average of $20.72.

More news about Marathon.

8. Chembio Diagnostics (CEMI) – -9.28%

Chembio Diagnostics, Inc., along with its affiliates, creates, produces, and markets point-of care (POC), diagnostic tests used for diagnosing or diagnosing diseases. It offers testing for COVID-19 and HIV/Syphilis. The company also offers tests for dengue, HIV, Syphilis, Chagas and chikungunya. It sells products under the STAT PAK, STURE CHECK and STAT VIEW trademarks. The private labels of marketing partners are also used to market its products to hospitals and medical labs. The company has agreements with The Bill & Melinda Gates Foundation and The Paul G. Allen Family Foundation and The Oswaldo Cruz Foundation. It also works closely with U.S. government agencies such as the Centers for Disease Control and Prevention and Biomedical Advanced and Research and Development Authority of U.S. Department of Health and Human Services and U.S. Department of Agriculture. Chembio Diagnostics, Inc., was established in 1985. It is located in Hauppauge, New York.

NASDAQ ended the session with Chembio Diagnostics falling 9.28% to $0.44 on Friday while NASDAQ fell 0.9% to $11,448.40.

Volume

Today’s last reported volume for Chembio Diagnostics is 518670 which is 63.96% below its average volume of 1439230.

Chembio Diagnostics’s last close was $0.49, 83.33% below its 52-week high of $2.94.

Chembio Diagnostics’s Sales

Chembio Diagnostics’s sales growth is 21.4% for the present quarter and a decline by 29.5% for the next. The company’s growth estimates for the current quarter and the next is 57.8% and 20.8%, respectively.

Chembio Diagnostics’s Revenue

Year-on-year quarterly revenue growth grew by 115.7%, now sitting on 57.91M for the twelve trailing months.

Chembio Diagnostics’s Stock Yearly Top and Bottom Value

Chembio Diagnostics’s stock is valued at $0.44 at 17:33 EST, way below its 52-week high of $2.94 and above its 52-week low of $0.42.

Chembio Diagnostics’s Moving Average

Chembio Diagnostics’s value is way below its 50-day moving average of $0.75 and way under its 200-day moving average of $0.88.

More news about Chembio Diagnostics.

9. Pacific Biosciences of California (PACB) – -8.47%

Pacific Biosciences of California, Inc. develops, manufactures, and markets sequencing systems for complex genetic problems. PacBio’s Systems are used to monitor and analyze biochemical sequence reactions. The company also offers consumables such as single molecule real time (SMRT), cells and various reagent kit designs for specific workflows. For example, the template preparation kit is used to convert DNA into SMRTbell double stranded library formats. This includes molecular biology reagents such as ligase and buffers. The company also sells binding kits such as the modified DNA polymerase, which is used to bind SMRTbell library to the polymerase to prepare for sequencing. Sequencing kits include reagents that are required to perform on-instrument real-time sequencing including the phospholinked nuclear nucleotides. It serves commercial labs; research centers; genome centres; hospitals, public health laboratories, clinical research institutes, contract researchers organizations, academic institutions, pharmaceutical companies, and agricultural businesses. The company markets its products via a direct sales force throughout North America and Europe as well as distribution partners across Asia, Europe and the Middle East. Invitae Corporation has signed a partnership agreement for Pacific Biosciences of California, Inc.’s development and commercialization. The company used to be known as Nanofluidics, Inc. but changed its name in 2005 to Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc., was founded in 2000. It is located in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California sliding 8.47% to $6.05 on Friday, following the last session’s upward trend. NASDAQ slid 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 6319540 which is 21.61% below its average volume of 8061770.

Pacific Biosciences of California’s last close was $6.61, 78.75% below its 52-week high of $31.10.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 16.6% for the current quarter and 27.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 52.4% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 134.69M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $6.05 at 17:33 EST, way below its 52-week high of $31.10 and way above its 52-week low of $3.85.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is higher than its 50-day moving average of $5.68 and way below its 200-day moving average of $9.74.

More news about Pacific Biosciences of California.

10. Xenetic Biosciences (XBIO) – -8.47%

Xenetic Biosciences, Inc. is a biopharmaceutical firm that focuses on advancing XCART, a customized chimeric receptor T cell (CART) platform technology designed to target specific patient-specific tumour neoantigens. It is involved in research and development of oncology therapies and biologic drugs. Cell-based therapies that target the B-cell receptor are developed to treat B-cell lymphomas. By partnering with pharmaceutical and biotech companies, it is also using PolyXen, their proprietary drug delivery platform. Takeda Pharmaceutical Co. Ltd. and Serum Institute of India Limited have signed collaboration agreements. Xenetic Biosciences, Inc. has its headquarters in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences falling 8.47% to $0.66 on Friday, after two successive sessions in a row of gains. NASDAQ fell 0.9% to $11,448.40, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Xenetic Biosciences is 71110 which is 50.06% above its average volume of 47385.

Xenetic Biosciences’s last close was $0.72, 71.89% under its 52-week high of $2.57.

The company’s growth estimates for the current quarter and the next is 20% and 15.4%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 103.4%, now sitting on 1.36M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be overbought (>=80).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $0.66 at 17:33 EST, way below its 52-week high of $2.57 and way higher than its 52-week low of $0.45.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way under its 50-day moving average of $0.84 and way below its 200-day moving average of $0.97.

More news about Xenetic Biosciences.

Stay up to date with our winners and losers daily report